1. Home
  2. MYNZ vs FRSX Comparison

MYNZ vs FRSX Comparison

Compare MYNZ & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • FRSX
  • Stock Information
  • Founded
  • MYNZ 2021
  • FRSX N/A
  • Country
  • MYNZ Germany
  • FRSX Israel
  • Employees
  • MYNZ N/A
  • FRSX N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • FRSX Computer Software: Prepackaged Software
  • Sector
  • MYNZ Health Care
  • FRSX Technology
  • Exchange
  • MYNZ Nasdaq
  • FRSX Nasdaq
  • Market Cap
  • MYNZ 7.9M
  • FRSX 8.2M
  • IPO Year
  • MYNZ 2021
  • FRSX 2017
  • Fundamental
  • Price
  • MYNZ $1.58
  • FRSX $2.09
  • Analyst Decision
  • MYNZ Buy
  • FRSX
  • Analyst Count
  • MYNZ 2
  • FRSX 0
  • Target Price
  • MYNZ $14.00
  • FRSX N/A
  • AVG Volume (30 Days)
  • MYNZ 74.3K
  • FRSX 75.7K
  • Earning Date
  • MYNZ 10-21-2025
  • FRSX 09-21-2025
  • Dividend Yield
  • MYNZ N/A
  • FRSX N/A
  • EPS Growth
  • MYNZ N/A
  • FRSX N/A
  • EPS
  • MYNZ N/A
  • FRSX N/A
  • Revenue
  • MYNZ $893,991.00
  • FRSX $452,000.00
  • Revenue This Year
  • MYNZ $26.06
  • FRSX N/A
  • Revenue Next Year
  • MYNZ $4.97
  • FRSX N/A
  • P/E Ratio
  • MYNZ N/A
  • FRSX N/A
  • Revenue Growth
  • MYNZ N/A
  • FRSX N/A
  • 52 Week Low
  • MYNZ $1.30
  • FRSX $1.98
  • 52 Week High
  • MYNZ $16.04
  • FRSX $18.41
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 42.09
  • FRSX 32.79
  • Support Level
  • MYNZ $1.58
  • FRSX $2.30
  • Resistance Level
  • MYNZ $1.79
  • FRSX $2.63
  • Average True Range (ATR)
  • MYNZ 0.10
  • FRSX 0.21
  • MACD
  • MYNZ -0.00
  • FRSX 0.01
  • Stochastic Oscillator
  • MYNZ 6.52
  • FRSX 15.44

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: